Review
Nature Reviews Cancer 8, 523-534 (July 2008) | doi:10.1038/nrc2439
MYB function in normal and cancer cells
Robert G. Ramsay1 & Thomas J. Gonda2 About the authors
Abstract
The transcription factor MYB has a key role as a regulator of stem and progenitor cells in the bone marrow, colonic crypts and a neurogenic region of the adult brain. It is in these compartments that a deficit in MYB activity leads to severe or lethal phenotypes. As was predicted from its leukaemogenicity in several animal species, MYB has now been identified as an oncogene that is involved in some human leukaemias. Moreover, recent evidence has strengthened the case that MYB is activated in colon and breast cancer: a block to MYB expression is overcome by mutation of the regulatory machinery in the former disease and by oestrogen receptor-
(ER) in the latter.
- View At a Glance
Author affiliations
- Peter MacCallum Cancer Centre, St Andrew's Place, Melbourne, Victoria 3002, Australia.
- University of Queensland Diamantina Institute for Cancer, Immunology and Metabolic Medicine, Princess Alexandra Hospital, Ipswich Road, Buranda, Queensland 4102, Australia.
Correspondence to: Robert G. Ramsay1 Email: rob.ramsay@petermac.org
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Oncogenic intelligence: Evidence of a hit-and-run tumour virusNature News and Views (02 Jun 1983)
Oncogenic intelligence: Viral oncogene permutationsNature News and Views (01 Dec 1983)
RESEARCH
Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemiaNature Letters to Editor (19 Jul 1984)
Nucleotide sequence of chicken c-myb complementary DNA and implications for myb oncogene activationNature Letters to Editor (13 Feb 1986)
See all 22 matches for Research